Your account is not claimed yet. You can sign up with ORCID to claim your account.

Max Senna Mano (Max Mano, Max S Mano, Max S Mano)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 14

Top Venues

Future oncology (London, England)

JCO global oncology

Clinics (Sao Paulo, Brazil)

Sao Paulo medical journal = Revista paulista de medicina

This page only lists publications with an associated author ORCID identifier.

Publications

Cristiano A A Resende, Rodrigo Dienstmann, Max Senna Mano
Reply to R. Freitas-Junior et al. JCO global oncology 9 (2023)
Ana I M Kazzi, Paulo Henrique Costa Diniz, Max Senna Mano, Angélica Nogueira-Rodrigues
Challenging Outlook of Caring for Adolescents and Young Adults With Cancer in Brazil: Results of a Nationwide Survey. JCO global oncology 9 (2023)
Thamirys U Menezes, Márcia Mp Serra, Carlos Henrique Barrios, Leandro Jonata Carvalho Oliveira, Vânia Sp Godo, Fanny Cascelli, Renan O Clara, Gustavo C L Gössling, Gustavo Werutsky, Max Senna Mano
Results of a survey study on health professionals' perceptions of tumor boards in Brazil. Future oncology (London, England) (2023)
Carsten Denkert, Chiara Lambertini, Peter Andreas Fasching, Katherine L Pogue-Geile, Max Senna Mano, Michael Untch, Norman Wolmark, Chiun-Sheng Huang, Sibylle Loibl, Eleftherios P P Mamounas, Charles E Geyer, Peter C Lucas, Thomas Boulet, Chunyan Song, Gail D Lewis Phillips, Malgorzata Nowicka, Sanne de Haas, Mark Basik
Biomarker Data From the Phase III KATHERINE Study of Adjuvant T-DM1 Versus Trastuzumab for Residual Invasive Disease After Neoadjuvant Therapy for HER2-Positive Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Cristiano A A Resende, Heloísa M Fernandes Cruz, Matheus Costa E Silva, Rafael D Paes, Rodrigo Dienstmann, Carlos Henrique Barrios, Aline C Goncalves, Fanny G A Cascelli, Andreza K B A Souto, Leandro Jonata Carvalho Oliveira, Tomás Reinert, Diocesio Alves Pinto de Andrade, Mauro P Passos, Eduardo Camargo Millen, Felipe Pereira Zerwes, Paulo L Moraes, Bruno L Ferrari, Max Senna Mano
Impact of the COVID-19 Pandemic on Cancer Staging: An Analysis of Patients With Breast Cancer From a Community Practice in Brazil. JCO global oncology 8 (2022)
Max Senna Mano
Borderline indications for ovarian suppression: addressing uncertainties with patients. Future oncology (London, England) 18 (37) (2022)
Max Senna Mano
Borderline indications for ovarian suppression: addressing uncertainties with patients. Future oncology (London, England) (2022)
Max Senna Mano
Borderline indications for ovarian suppression: addressing uncertainties with patients. Future oncology (London, England) 18 (37) (2022)
Max Senna Mano
Borderline indications for ovarian suppression: addressing uncertainties with patients. Future oncology (London, England) (2022)
Max Senna Mano, Fadil T Çitaku, Paul Barach
Implementing multidisciplinary tumor boards in oncology: a narrative review. Future oncology (London, England) (2021)
Laura Testa, Max Senna Mano, Roberto Jun Arai, Renata Colombo Bonadio, Sergio Vicente Serrano, Marina M Costa Zorzetto, Susanne Crocamo Ventilari da Costa, Oren Smaletz, Rui Gilberto Ferreira, Paulo Marcelo Gehm Hoff
Phase II trial of humanized anti-Lewis Y monoclonal antibody for advanced hormone receptor-positive breast cancer that progressed following endocrine therapy. Clinics (Sao Paulo, Brazil) 76 (2021)
Max Senna Mano
Interfaces between medical practice and trading: lessons from the markets. Postgraduate medical journal 97 (1149) (2021)
Max Senna Mano
Trastuzumab emtansine: a game changer in HER2-positive early breast cancer. Future oncology (London, England) 16 (32) (2020)
Alfredo Carlos Simões Dornellas de Barros, Heloisa de Andrade Carvalho, Felipe Eduardo Martins de Andrade, Cristiane da Costa Bandeira Abrahão Nimir, Marcelo Moura Costa Sampaio, Fabiana Baroni Alves Makdissi, Max Senna Mano
Mammary adenectomy followed by immediate reconstruction for treatment of patients with early-infiltrating breast carcinoma: a cohort study. Sao Paulo medical journal = Revista paulista de medicina 137 (4) (2019)

Max Senna Mano.css-eqlu8i{font-size:small;padding-left:4px;} (Max Mano, Max S Mano, Max S Mano)

Publication Activity (10 Years)

Top Topics

Top Venues

Max Senna Mano (Max Mano, Max S Mano, Max S Mano)